Hier vind je alle referenties van onderzoeken die gebruikt zijn in verschillende materialen.

  • Brochure Probiotica bij antibiotica
    • 1) McFarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis. 1998 Sep-Oct;16(5):292-307 
      2) Agamennone et al. BMC A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The Netherlands, Gastroenterology. 2018; 18:103. 
      3) McFarland LV. Emerging therapies for Clostridium difficile infections. Expert Opin Emerging Drugs; 2011. 16 (3): 425-439. 
      4) Claassen E. Cost-benefi t relation of diet and probiotics in iatrogenic bowel irregularity (IBI). Frontiers in Pharmacology. 2014;5:14. 
      5) Videlock E.J., Cremonini F. Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2012; 35: 1355-1369. 
      6) Hempel, S. et al. Probiotics for the Prevention and Treatment of Antibiotic-Associated Diarrhea, A Systematic Review and Meta-analysis. JAMA. 2012;307(18):1959-1969. 
      7) Goldenberg JZ. et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017;12(12):CD006095.  
      8) Szajewska H. et al. Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Children. J Pediatr Gastroenterol Nutr. 2016;62(3):495-506.   
      9) Wong S. et alLactobacillus casei Shirota probiotic drink reduces antibiotic-associated diarrhoea in patients with spinal cord injuries: a randomised controlled trial. Br J Nutr. 2014 ; 111 (4): 672-8 
      10) Pirker A. et al. Effects of antibiotic therapy on the gastrointestinal microbiota and the infl uence of Lactobacillus casei. Food and Agricultural Immunology 2013;24(3):315-330 
      11) Stockenhuber, A. et alPreventing Antibiotic Associated Diarrhoea using a Probiotic Lactobacillus casei Preparation. Gut 2008; 57 (Suppl II) A20
      12) Lee L. et al. Prevention of relapse following Clostridium difficile infection using probiotic Lactobacillus casei Shirota. International Journal of Probiotics & Prebiotics. 2013; 8(4):145-148.
      13) Flach J, et al. The underexposed role of food matrices in probiotic products: Reviewing the relationship between carrier matrices and product parameters. Crit Rev Food Sci Nutr. 2018;58(15):2570-2584.  
      14) Ouwehand A. et al. Effectiveness of Multi-strain Versus Single-strain Probiotics: Current Status and Recommendations for the Future, J Clin Gastroenterol. 52():S35–S40, NOV 2018 
      15) Lee B. et al Attenuation of colitis by Lactobacillus casei BL23 is dependent on the dairy delivery matrix. Appl Environ Microbiol. 2015;81(18):6425-35.  
      16) Burgain J. Encapsulation of Lactobacillus rhamnosus GG in microparticles: Influence of casein to whey protein ratio on bacterial survival during digestion. Innovative Food Science & Emerging Technologies. 2013. 19: 233–242 
      17) Agamennone V. et al. Een praktische gids voor probiotica ter preventie van antibiotica-gerelateerde diarree in Nederland. Nederlands Platform voor Farmaceutisch Onderzoek. 2019;4:a1689 
      18) Guo Q, et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database of Systematic Rev. 2019; 4(4): CD004827. 
      19) Former, M. Probiotica als aanvullende therapie bij antibioticum geassocieerde diarree, Voeding en Visie, 2001. 24. 2: 6-7. 
      20) Hickson M. et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007 ;335(7610):80 
      21) ISAPP Probiotic Guide
  • Brochure Onderzoek met probiotica bij ouderen
    • 1. Berg, S. van den, et al. Voeding in relatie tot aandoeningen en medicijngebruik bij ouderen. Rijksinstituut voor Volksgezondheid en Milieu. 2012; RIVM Rapport 350047001.
      2. Bouterse, M. et al. Huisartsenzorg in cijfers, Obstipatie, Huisarts en Wetenschap. 2010; 9:463-463
      3. Claesson M.J. et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012 Aug 9; 488(7410):178-84
      4. Flach, J. et al. Economic Potential of Probiotic Supplementation in Institutionalized Elderly with Chronic Constipation. PharmaNutrition. 2018. 6. 10.1016
      5. Duncan S.H., Flint H.J. Probiotics and prebiotics and health in ageing populations. Maturitas. 2013 May;75(1):44-50.
      6.Ocke M. et al. Diet of community-dwelling older adults : Dutch National Food Consumption Survey Older adults 2010-2012. Rijksinstituut voor Volksgezondheid en Milieu. RIVM Rapport 050413001.
      7. Chmielewska, A., Szajewska, H. Systematic review of randomised controlled trials: Probiotics for functional constipation, World J Gastroenterol, 2010, January 7; 16(1): 69–75
      8. Nieuwboer, M. van den, et al. Improving the bowel habits of elderly residents in a nursing home using probiotic fermented milk. Beneficial Microbes. 2015; Feb 17:1-8.
      9. Frazzitta, Giuseppe et al. Severe Constipation in Parkinson’s Disease and in Parkinsonisms: Prevalence and Affecting Factors. Frontiers in neurology vol. 10 621. 18 Jun. 2019
      10. Cassani, E. et al. Use of probiotics for the treatment of constipation in Parkinson’s disease patients. Minerva Gastroenterol Dietol. 2011; Jun;57(2):117-21.
      11. Tan, A.H. et al. Probiotics for Parkinson’s disease: Current evidence and future directions. JGH Open, (2021) 5: 414-419.
      12. Gras-Miralles, B., Cremonini, F. A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly, Clin Interv Aging. 2013; 8: 191–200.
      13. Gandell D. et al. Treatment of constipation in older people. CMAJ. 2013 May 14;185(8):663-70.
      14. Diemel, J.M. et al. NHG – Standaard Obstipatie, Huisarts en Wetenschap, 2010;53(9):484-98
      15. Gezondheidsraad. Richtlijn voor de vezelconsumptie. Den Haag: Gezondheidsraad, 2006; publicatie nr 2006/03.
      16. Ho, K.S. et al. Stopping or reducing dietary fiber intake reduces constipation and its associated symptoms, World J Gastroenterol, 2012 September 7; 18(33): 4593-4596
      17. Kenny, K. A., Skelly, J.M. Dietary fiber for constipation in older adults: a systematic review. Clinical Effectiveness in Nursing, 2001; 5: 120-128
      18. Fosnes GS, Lydersen S, Farup PG. Effectiveness of laxatives in elderly–a cross sectional study in nursing homes. BMC Geriatr. 2011 Nov 17;11:76.
      19. Lenoir-Wijnkoop I, et al. Probiotics Reduce Health Care Cost and Societal Impact of Flu-Like Respiratory Tract Infections in the USA: An Economic Modeling Study. Front Pharmacol. 2019 Aug 28;10:980
      20. Goldenberg JZ. et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017;12(12):CD006095. 
      21. Videlock, E.J., Cremonini, F. Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2012 Jun; 35(12):1355-69.
      22. McFarland L. Emerging therapies for Clostridium difficile infections. Expert Opin Emerg Drugs. 2011 Sep;16(3):425-39.
      23. Hempel S. et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012 May 9;307(18):1959-69.
      24. Hickson M. et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial.BMJ 2007;335:80.
      25. Stockenhuber, A. et al. Preventing Antibiotic Associated Diarrhoea using a Probiotic Lactobacillus casei Preparation. Gut 2008; 57 (Suppl II) A20
      26. Pirker, A. et al. Effects of antibiotic therapy on the gastrointestinal microbiota and the influence of Lactobacillus casei. Food and Agricultural Immunology, 2013; 24(3):315-330.
      27. Lee L. et al. Prevention of relapse following Clostridium difficile infection using probiotic Lactobacillus casei Shirota. International Journal of Probiotics & Prebiotics. 2013; 8(4):145-148.
  • Brochure Darmmicrobiota en ouder worden
    • 1) Claesson M.J. et alGut microbiota composition correlates with diet and health in the elderly.  Nature. 2012 Aug 9;488(7410):178-84. 
      2) Eldermet-project, University College Cork, Cork University Hospital, and Teagasc, Moorepark
      3) Ragonnaud, E., Biragyn, A. Gut microbiota as the key controllers of “healthy” aging of elderly people. Immun Ageing. 2021;18:2. 
      4) Roswall J, et al. Developmental trajectory of the healthy human gut microbiota during the first 5 years of life. Cell Host Microbe. 2021 May 12;29(5):765-776. 
      5) Duncan S.H., Flint H.J. Probiotics and prebiotics and health in ageing populations. Maturitas. 2013 May;75(1):44-50. 
      6) Tiihonen, K. et al. Human intestinal microbiota and healthy ageing. Ageing Res Rev. 2010 Apr; 9(2):107-16. 
      7) Berg, S. van den, et al. Voeding in relatie tot aandoeningen en medicijngebruik bij ouderen. Rijksinstituut voor Volksgezondheid en Milieu. 2012; RIVM Rapport 350047001. 
      8) Cevenini, E. et al. Inflamm-ageing. Curr Opin Clin Nutr Metab Care. 2013 Jan;16(1):14-20. 
      9) Bouterse, M. et alHuisartsenzorg in cijfers, Obstipatie, Huisarts en Wetenschap. 2010; 9:463-463 
      10) Flach, J. et al. Economic Potential of Probiotic Supplementation in Institutionalized Elderly with Chronic Constipation. PharmaNutrition. 2018. 6. 10.1016 
  • Brochure Probiotica en obstipatie
    • 1) Diemel, J.M. et al. NHG – Standaard Obstipatie, Huisarts en Wetenschap. 2010;53(9):484-98 
      2) Bouterse, M. et al. Huisartsenzorg in cijfers, Obstipatie, Huisarts en Wetenschap. 2010;9:463-463. 
      3) Shafe, A.C.E. et alThe LUCK study: Laxative Usage in patients with GP diagnosed Constipation in the UK, within the general population and in pregnancy. An epidemiological study using the General Practice Research Database (GPRD) Therap Adv Gastroenterol. 2011. 4(6): 343–363. 
      4) Milliano, I. de, et al. Is a multispecies probiotic mixture effective in constipation during pregnancy? ‘A pilot study’, Nutr J. 2012, 11:80 
      5) Bosshard, W. et al. The treatment of chronic constipation in elderly people: an update. Drugs Aging. 2004, 21(14):911-30 
      6) Gras-Miralles, B., Cremonini, F. A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly, Clin Interv Aging. 2013; 8: 191–200
      7) Flach J., Koks M., van der Waal M.B., Claassen E., Larsen O.F.A. Economic potential of probiotic supplementation in institutionalized elderly with chronic constipation (2018)  PharmaNutrition,  6  (4) , pp. 198-206. 
      8) Rome Foundation, Appendix A, Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders 
      9) Kumar, P., Clark, M. (eds.) Clinical Medicine. 2012 8th ed. Edinburgh: Elsevier Saunders 
      10) Chmielewska, A., Szajewska, H. Systematic review of randomised controlled trials: Probiotics for functional constipation, World J Gastroenterol. 2010; 16(1): 69–75 
      11) Gezondheidsraad. Richtlijn voor de vezelconsumptie. Den Haag: Gezondheidsraad, 2006; publicatie nr 2006/03. ISBN 90-5549-589-1 
      12) Ho, K.S. et al. Stopping or reducing dietary fiber intake reduces constipation and its associated symptoms, World J Gastroenterol, 2012; 7; 18(33): 4593-4596 
      13) Kenny, K. A., Skelly, J.M. Dietary fiber for constipation in older adults: a systematic review. Clin. Eff Nurs. 2001;5:120-128 
      14) Fosnes, G.S. et al. Effectiveness of laxatives in elderly – a cross sectional study in nursing homes. BMC Geriatr. 2011;11.76 
      15) Horst, H.E. van der, et al. NHG-Standaard Prikkelbaredarmsyndroom (PDS) (Eerste herziening) Huisarts en Wetenschap. 2012; 55(5):204-9 
      16) Koebnick, C. et al. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symtoms in patients with chronic constipation. Can J Gastroenterol. 2003; 17(11):655-9. 
      17) Yang Y.X. et al. Effect of a fermented milk containing Bifidobacterium lactis DN-173101 on Chinese constipated women. World J. Gastroenterol. 2008; 14: 6237-6243 
      18) Mollenbrink, M., Bruckschen, E. Treatment of chronic constipation with physiologic Escherichia coli bacteria. Results of a clinical study of the effectiveness and tolerance of  microbiological therapy with the E. coli Nissle 1917 strain (Mutaflor). Med Klin, 1994 (Munich) 89: 587–593 
      19) Ouwehand AC. et al. Effectiveness of Multi-strain Versus Single-strain Probiotics: Current Status and Recommendations for the Future, J Clin Gastroenterol. 2018; 52(suppl 1):S35–S40. 
      20) Lee B. et al. Attenuation of colitis by Lactobacillus casei BL23 is dependent on the dairy delivery matrix. Appl Environ Microbiol. 2015;81(18):6425-6435  
      21) Burgain J. Encapsulation of Lactobacillus rhamnosus GG in microparticles: Influence of casein to whey protein ratio on bacterial survival during digestion. Innovative Food Science & Emerging Technologies. 2013;(19): 233–242 
      22) Flach et al. The underexposed role of food matrices in probiotic products: Reviewing the relationship between carrier matrices and product parameters. Crit Rev Food Sci Nutr. 2018;58(15):2570-2584. 
      23) Ouwehand AC. A review of dose-responses of probiotics in  human  studies.  Benef ical Microbes. 2017;8(2):143-151.   
      24) ISAPP resources ‘What are probiotics?’
  • Stoelgangkaart
    • 1) Sakai T, et al. (2011) Int. J. Food Sci Nutr 62(4): 423-30.
      2) Matsumoto K, et al. (2006). Biosci Microflora 25(2): 39-48.
      3) Nieuwboer van den M, et al. (2015) Benef Microbes, 6(4): 397-403.
      4) Koebnick C, et al. (2003) Can J Gastroenterol; 17 (11):655-659.
      5) Krammer HJ, et al. (2011) Coloproctology, Volume 33, Number 2, p.109-113.
      6) Sugita T, et al. (1994) Jpn J Pediatr, 47, 2755-2762.
      7) Matsumoto K, et al. (2010) J Biosci Bioeng, 110(5):547-52.
      8) Sur D, et al. (2010) Epidem Inf, 139(6):919-26.
      9) Pirker A, et al. (2013) Food and Agric Immunol 24(3):315-330.
      10) Wong S, et al. (2014) Br J Nutr. Feb;111(4): 672-8.
      11) Thijssen AY, et al. (2016) Eur J Gastroenterol Hepatol. Jan;28(1):8-14.
      12) Barret JS, et al. (2008) World J Gastroenterol 14(32): 5020-5024.
      13) Gleeson M, et al. (2011) Int. J Sport Nutr Exer Metabol 21: 55-64.
      14) Cats A, et al. (2003) Aliment Pharmacol Ther, 17 (3):429-435.
      15) Ouwehand AC. (2017) Benefical Microbes 8(2):143-151.
      16) Hoveyda N, et al. (2009) BMCGastroenterol; 16 (9):1
  • Webinar De rol van de microbiota bij COVID-19
      • Cho & Blaser, (2012). Nature Rev Genetics, 13(4), 260-270
      • Rowan-Nash, et al. (2019). Microbiology and Molecular Biology Reviews, 83(1)
      • Laukens et al, FEMS Microbiology Reviews, 2016, Vol. 40, No. 1
      • Cani, Nature Reviews Gastroenterology & Hepatology, 14, 321-322,2017
      • Maynard, Craig L., et al. Nature 489.7415 (2012): 231-241
      • Arumugam, et al. (2011). Nature, 473(7346), 174-180
      • Round & Mazmanian, Nature Rev. Immunology, 2009
      • Dogra, S. K., Doré, J., & Damak, S. (2020). Frontiers in Microbiology, 11, 2245
      • https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19—28-september-2021
      • De Oliveira, Gislane Lelis Vilela, et al. Frontiers in Immunology 12 (2021): 214
      • Dhar, Debojyoti, and Abhishek Mohanty. Virus research (2020): 198018.
      • Yeoh, Yun Kit, et al. Gut 70.4 (2021): 698-706.
      • Dickson, Robert P. “Lung microbiota and COVID-19 severity.” Nature Microbiology (2021): 1-2.
      • Sulaiman, Imran, et al. “Microbial signatures in the lower airways of mechanically ventilated COVID19 patients associated with poor clinical outcome.” Nature microbiology (2021).
      • De Oliveira, Gislane Lelis Vilela, et al. Frontiers in Immunology 12 (2021): 214.
      • Kompaniyets, Lyudmyla, et al. “Peer Reviewed: Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021.” Preventing Chronic Disease 18 (2021).
      • Friedland & Haribabu. EBioMedicine 61 (2020).
      • Bach, J. F. (2002). New England journal of medicine, 347(12), 911-920.
      • Cepon-Robins, T. J., & Gildner, T. E. (2020). Evolution, Medicine, and Public Health, 2020(1), 234-248.
      • https://www.news-medical.net/health/What-are-Helminths.aspx
      • Finlay, B. Brett, et al. Proceedings of the National Academy of Sciences 118.6 (2021)
      • Louca, Panayiotis, et al. BMJ nutrition, prevention & health (2021).
      • Baud, David, et al. Frontiers in public health 8 (2020): 186
      • Zhang, Lina, et al. Therapeutic advances in gastroenterology 14 (2021): 17562848211035670.
      • Lynn, David J., et al. Nature Reviews Immunology (2021): 1-14.
      • Zimmermann & Curtis. Vaccine 36.2 (2018): 207-213.
      • Kootte, Ruud S., et alCell metabolism 26.4 (2017): 611-619
      • Larsen, Olaf FA, et al. Scientific reports 9.1 (2019): 1-6.
  • Webinar Chrono-Nutrition: je bent wat en wanneer je eet
    • 1. Pot GK, Voshol PJ, Kaldenberg E, van Eekelen A. Je bent niet alleen wat je eet, maar ook wanneer je eet. Ned Tijdschr voor Voeding en Diet. 2021 Juni
      2. Gezondheidsraad. Gezondheidsrisico’s door nachtwerk. Den Haag; 2017. Available from: https://www.gezondheidsraad.nl/binaries/gezondheidsraad/documenten/adviezen/2017/10/24/gezondheidsrisicos-door-nachtwerk/achtergronddocument-Gezondheidsrisico%27s-door-nachtwerk.pdf
      3. Oike H, Oishi K, Kobori M. Nutrients, Clock Genes, and Chrononutrition. Curr Nutr Rep. 2014 Jan;3(3):204–12.
      4. Tahara Y, Shibata S. Chronobiology and nutrition. Neuroscience. 2013 Dec 3;253(3):78–88.
      5. Voigt RM, Forsyth CB, Green SJ, Mutlu E, Engen P, Vitaterna MH, et al. Circadian disorganization alters intestinal microbiota. PLoS One. 2014;9(5):e97500.
      6. Liang X, FitzGerald GA. Timing the Microbes: The Circadian Rhythm of the Gut Microbiome: Journal of Biological Rhythms. 2017 Sep 1;32(6):505-515.
      7. Pot GK, Hardy R, Stephen AM. Irregular consumption of energy intake in meals is associated with a higher cardio-metabolic risk in adults of a British birth cohort. Int J Obes. 2014;38(12):1518–24.
      8. Pot GK, Hardy R, Stephen AM. Irregularity of energy intake at meals: prospective associations with the metabolic syndrome in adults of the 1946 British birth cohort. Br J Nutr. 2016;115(2):315–23.
      9. Bandín C, Martinez-Nicolas A, Ordovás JM, Madrid JA, Garaulet M. Circadian rhythmicity as a predictor of weight-loss effectiveness. Int J Obes. 2014 Aug 15 ;38(8):1083–8.
      10. Schoenfeld BJ, Aragon AA, Krieger JW. Effects of meal frequency on weight loss and body composition: a meta-analysis. Nutr Rev. 2015 Mar 1;73(2):69-82.
      11. Moon S, Kang J, Kim SH, Chung HS, Kim YJ, Yu JM, et al. Beneficial effects of time-restricted eating on metabolic diseases: A systemic review and meta- analysis. Vol. 12, Nutrients. MDPI AG; 2020. p. 1267.
      12. Muñoz JSG, Gomez Gallego M, Diaz Soler I, Ortega MCB, Martinez Caceres CM, Morante JJH. Effect of a chrono-type-adjusted diet on weight loss effectiveness: A randomized clinical trial. Clin Nutr 2020 Apr;39(4):1041-1048.
      13. Al Khatib HK, Harding SV, Darzi J, Pot GK. The effects of partial sleep deprivation on energy balance: a systematic review and meta-analysis. Eur J Clin Nutr. 2017;71(5):614–24.